TABLE 3.
Group | No. oocytes | GV | MI | MII | DEG | NN |
SOF + BSA + FBS | 71 | 16 (22.5%)a | 37 (52.1%)a | 3 (4.2%)a | 7 (9.8%)a,b | 8 (11.2%)a |
SOF + BSA + FBS + 1 μl/ml ITS | 81 | 16 (19.7%)a | 32 (39.5%)a | 16 (19.7%)b | 7 (8.6%)a | 10 (12.3%)a |
SOF + BSA + FBS + 10 μl/ml ITS | 80 | 16 (20%)a | 29 (36.2%)a | 5 (6.2%)a | 17 (21.2%)b | 13 (16.2%)a |
SOF + BSA + FBS (control): COCs cultured in SOF + 8% BSA + 2.5% FBS; SOF + BSA + FBS + 1 μl/ml ITS: COCs cultured in SOF + 8% BSA + 2.5% FBS and 1 μl/ml ITS; and SOF + BSA + FBS + 10 μl/ml ITS: COCs cultured in SOF + 8% BSA + 2.5% FBS and 10 μl/ml ITS. The percentages of oocytes in the germinal vesicle (GV), metaphase I (MI), metaphase II (MII), degenerated (DEG), and non-identifiable (NN) stages was recorded. In the same column, percentages with different superscripts differed significantly (a,bp < 0.05). The experiments were repeated three times (n = 3).
BSA, bovine serum albumin; COC, cumulus–oocyte complex; FBS, fetal bovine serum; ITS, insulin-transferrin-selenium; IVM, in vitro maturation; SOF, synthetic oviductal fluid.